|
C1ORF131 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.3622999999473E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.74373999999311E-05 |
| Normal-vs-Stage2 |
3.481100E-03 |
| Normal-vs-Stage3 |
3.023400E-03 |
| Normal-vs-Stage4 |
1.121220E-03 |
| Stage1-vs-Stage2 |
7.060600E-01 |
| Stage1-vs-Stage3 |
4.673600E-01 |
| Stage1-vs-Stage4 |
8.360400E-01 |
| Stage2-vs-Stage3 |
4.331200E-01 |
| Stage2-vs-Stage4 |
8.772800E-01 |
| Stage3-vs-Stage4 |
4.846800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.3123999999839E-06 |
| Normal-vs-AfricanAmerican |
2.618400E-02 |
| Normal-vs-Asian |
3.60150000000559E-05 |
| Caucasian-vs-AfricanAmerican |
6.559600E-01 |
| Caucasian-vs-Asian |
5.029800E-02 |
| AfricanAmerican-vs-Asian |
5.494400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.41240000000187E-05 |
| Normal-vs-Female |
8.73810000023845E-07 |
| Male-vs-Female |
1.771610E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.895650E-02 |
| Normal-vs-Age(41-60Yrs) |
1.96556999999542E-05 |
| Normal-vs-Age(61-80Yrs) |
4.32449999999696E-05 |
| Normal-vs-Age(81-100Yrs) |
4.865000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.820600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.286800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.159230E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.469600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.642550E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.965960E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.24399999999569E-05 |
| Normal-vs-Grade 2 |
1.57940000000689E-06 |
| Normal-vs-Grade 3 |
6.354700E-04 |
| Normal-vs-Grade 4 |
4.763200E-03 |
| Grade 1-vs-Grade 2 |
1.594220E-01 |
| Grade 1-vs-Grade 3 |
4.314400E-02 |
| Grade 1-vs-Grade 4 |
5.860100E-02 |
| Grade 2-vs-Grade 3 |
1.343200E-01 |
| Grade 2-vs-Grade 4 |
7.165800E-01 |
| Grade 3-vs-Grade 4 |
5.516400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.09820000005723E-07 |
| Normal-vs-ccB subtype |
3.076600E-03 |
| ccA subtype-vs-ccB subtype |
1.257760E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.036500E-04 |
| Normal-vs-N1 |
9.774200E-02 |
| N0-vs-N1 |
4.824400E-01 |
|
|
